DE69429202D1 - Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes - Google Patents

Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes

Info

Publication number
DE69429202D1
DE69429202D1 DE69429202T DE69429202T DE69429202D1 DE 69429202 D1 DE69429202 D1 DE 69429202D1 DE 69429202 T DE69429202 T DE 69429202T DE 69429202 T DE69429202 T DE 69429202T DE 69429202 D1 DE69429202 D1 DE 69429202D1
Authority
DE
Germany
Prior art keywords
diseases
therapeutic agent
digestive tract
digestive
tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69429202T
Other languages
English (en)
Other versions
DE69429202T2 (de
Inventor
Seiki Matsuno
Iwao Sasaki
Akira Ohneda
Kazuyuki Sasaki
Yohei Natori
Tomohisa Nagasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Application granted granted Critical
Publication of DE69429202D1 publication Critical patent/DE69429202D1/de
Publication of DE69429202T2 publication Critical patent/DE69429202T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69429202T 1993-02-24 1994-02-24 Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes Expired - Fee Related DE69429202T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3526693 1993-02-24
JP25979993 1993-10-18
JP5326698A JP2961045B2 (ja) 1993-02-24 1993-12-24 腸管粘膜増強促進剤

Publications (2)

Publication Number Publication Date
DE69429202D1 true DE69429202D1 (de) 2002-01-10
DE69429202T2 DE69429202T2 (de) 2002-05-23

Family

ID=27288705

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69429202T Expired - Fee Related DE69429202T2 (de) 1993-02-24 1994-02-24 Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes

Country Status (5)

Country Link
US (2) US5432156A (de)
EP (1) EP0612531B1 (de)
JP (1) JP2961045B2 (de)
CA (1) CA2115377A1 (de)
DE (1) DE69429202T2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2961045B2 (ja) * 1993-02-24 1999-10-12 日清製粉株式会社 腸管粘膜増強促進剤
DE4334124A1 (de) 1993-03-04 1994-09-08 Bosch Gmbh Robert Vorrichtung zum Aufnehmen eines Elektromotors
JP2814892B2 (ja) * 1993-10-18 1998-10-27 日清製粉株式会社 消化管運動抑制剤
JP2887063B2 (ja) * 1993-12-28 1999-04-26 日清製粉株式会社 グリセンチンの製造方法
JP2729159B2 (ja) * 1994-10-31 1998-03-18 日清製粉株式会社 ヒトグリセンチンのモノクローナル抗体、この抗体を産生するハイブリドーマおよびそれを用いるヒトグリセンチンの定量法
US5702922A (en) * 1994-11-29 1997-12-30 Nisshin Flour Milling Co., Ltd. Method for the extraction of glicentin or glicentin analogous substances
US5789379A (en) * 1995-04-14 1998-08-04 Allelix Biopharmaceutical Inc. Glucagon-like peptide-2 analogs
US5834428A (en) * 1995-04-14 1998-11-10 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
US6184201B1 (en) * 1995-04-14 2001-02-06 Nps Allelix Corp. Intestinotrophic glucagon-like peptide-2 analogs
US5990077A (en) 1995-04-14 1999-11-23 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
EP2218734B1 (de) 1996-04-12 2013-06-05 1149336 Ontario Inc. Analoge des Glucagon ähnlichen Peptides-2
US5994500A (en) * 1996-07-19 1999-11-30 1149336 Ontario Inc. Antagonists of intestinotrophic GLP-2 peptides
CA2236519C (en) 1997-05-02 2011-09-13 1149336 Ontario Inc. Methods of enhancing functioning of the large intestine
US6051557A (en) * 1997-05-16 2000-04-18 1149336 Ontario Inc. Methods of enhancing functioning of the upper gastrointestinal tract
US6335317B1 (en) * 1998-04-10 2002-01-01 Emory University Use of gut-trophic growth factors to improve oxidative status
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
DE60230818D1 (de) * 2001-09-24 2009-02-26 Imp Innovations Ltd Pyy3-36 zur zur reduzierung oder vorbeugung von fettleibigkeit
US8058233B2 (en) * 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
GB0300571D0 (en) * 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
ES2361095T5 (es) * 2005-05-04 2021-11-23 Zealand Pharma As Análogos del péptido 2 tipo glucagón (GLP-2)
GB0511986D0 (en) * 2005-06-13 2005-07-20 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
JP5819586B2 (ja) 2006-11-08 2015-11-24 ジーランド ファーマ アクティーゼルスカブ 選択的グルカゴン様ペプチド−2(glp−2)類似体
TWI428346B (zh) * 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
KR20150006052A (ko) 2012-05-03 2015-01-15 질랜드 파마 에이/에스 글루카곤-유사 펩타이드-2 (glp-2) 유사체
JP6563614B1 (ja) 2016-12-09 2019-08-21 ジーランド・ファーマ・ア/エス アシル化glp−1/glp−2二重アゴニスト

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04364199A (ja) * 1990-08-15 1992-12-16 Nisshin Flour Milling Co Ltd ヒト型グリセンチンの合成遺伝子
CA2099476A1 (en) * 1992-07-13 1994-01-14 Akira Ohneda Medicaments comprising glicentin as active ingredient
JP2961045B2 (ja) * 1993-02-24 1999-10-12 日清製粉株式会社 腸管粘膜増強促進剤

Also Published As

Publication number Publication date
US5432156A (en) 1995-07-11
DE69429202T2 (de) 2002-05-23
US5547938A (en) 1996-08-20
JP2961045B2 (ja) 1999-10-12
EP0612531A1 (de) 1994-08-31
EP0612531B1 (de) 2001-11-28
JPH07223967A (ja) 1995-08-22
CA2115377A1 (en) 1994-08-25

Similar Documents

Publication Publication Date Title
DE69429202D1 (de) Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes
HK1037320A1 (en) Use of anti.microtubule agents for treating inflammatory respiratory diseases of the respiratory tract
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
DE69525293D1 (de) Inhalationsgerät für medizinische Zwecke
EE9900469A (et) Sulfoonamiidid endoteliini vahendatud haiguste raviks
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
NZ501069A (en) Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
EP0777474A4 (de) Verfahren zur behandlung von entzündlichen gelenkerkrankungen
AU9551298A (en) Use of coumarin derivatives for the treatment of digestive tract disorders
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
DE69722178D1 (de) Therapeutischer wirkstoff für augenerkrankungen
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
EP0755262A4 (de) Zubereitung für die behandlung von lungenerkrankungen
GB9416865D0 (en) Treatment of inflammatory diseases of the gastro-intestinal tract
AU653359B2 (en) Hardening agent for affected tissues of the digestive system
IT1293464B1 (it) Apparecchio elettromedicale per la cura di patologie infiammatorie acute
BR1100885A (pt) imidazopiridinas e sua aplicação para o tratamento de doenças gastro-intestinais
LV5179A3 (lv) Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai
KR970020845U (ko) 근골격계질환 치료보조용 테이프

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee